Marine-derived Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Phenol, Steroid, Ether, Peptide, Other); Source (Algae, Invertebrates, Microorganisms); Mode of Delivery (Anti-microbial, Anti-tumor, Anti-cardiovascular, Anti-viral, Anti-inflammatory, Others); End Users (Hospital and Clinics, Pharmacy, Others); and Geography

Report Code: TIPRE00023145 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Non-Imaging Diagnostic catheters are flexible tubes designed to deliver radiopaque media, guidewires, and therapeutic agents to selected sites in the vascular system. These are used to navigate cardiac anatomy, capture critical cardiac information, and deliver more precise therapy. The diagnostic catheters are designed to help facilitate comprehensive data collection and meet patients' needs from simple to complex cases.

MARKET DYNAMICS

The growth in number of minimally invasive surgical procedures, and technological advancements in imaging catheters will spur the demand for non-imaging diagnostic catheter. Additionally, rapid growth in geriatric population and growing prevalence of CVD's expected to boost the market growth to significant extent over the forecast period. However, reuse of disposable diagnostic catheters, and dearth of skilled professionals may restraint the growth of the market in the forecasted period.

MARKET SCOPE

The "Global Non-imaging diagnostic catheter Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of non-imaging diagnostic catheter market with detailed market segmentation by product, end-users, and geography. The global non-imaging diagnostic catheter market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading non-imaging diagnostic catheter market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global non-imaging diagnostic catheter market is segmented into product, and end-users. Based on product, the global non-imaging diagnostic catheter market is segmented into temperature monitoring catheters, pressure and hemodynamic monitoring catheters, and other non-imaging catheters. Based on the end-users, the non-imaging diagnostic catheter market is segmented into hospitals, and imaging and diagnostic centers.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global non-imaging diagnostic catheter market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The non-imaging diagnostic catheter market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting non-imaging diagnostic catheter market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the non-imaging diagnostic catheter market in these regions.



Get more information on this report :

MARKET PLAYERS


The reports cover key developments in the non-imaging diagnostic catheter market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from non-imaging diagnostic catheter market are anticipated to lucrative growth opportunities in the future with the rising demand for non-imaging diagnostic catheter in the global market. Below mentioned is the list of few companies engaged in the non-imaging diagnostic catheter market.

The report also includes the profiles of key non-imaging diagnostic catheter market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Johnson and Johnson
  •   B. Braun Melsungen AG
  •   C.R. Bard
  •   Medtronic
  •   Cardinal Health
  •   Boston Scientific
  •   St. Jude Medical
  •   Terumo Corporation
  •   Koninklijke Philips N.V.
  •   Edward LifeSciences

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Marine-derived Drugs Market - By Type
1.3.2 Marine-derived Drugs Market - By Source
1.3.3 Marine-derived Drugs Market - By Mode of Delivery
1.3.4 Marine-derived Drugs Market - By End Users
1.3.5 Marine-derived Drugs Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MARINE-DERIVED DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MARINE-DERIVED DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MARINE-DERIVED DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. MARINE-DERIVED DRUGS - GLOBAL MARKET OVERVIEW
6.2. MARINE-DERIVED DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. MARINE-DERIVED DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PHENOL
7.3.1. Overview
7.3.2. Phenol Market Forecast and Analysis
7.4. STEROID
7.4.1. Overview
7.4.2. Steroid Market Forecast and Analysis
7.5. ETHER
7.5.1. Overview
7.5.2. Ether Market Forecast and Analysis
7.6. PEPTIDE
7.6.1. Overview
7.6.2. Peptide Market Forecast and Analysis
7.7. OTHER
7.7.1. Overview
7.7.2. Other Market Forecast and Analysis
8. MARINE-DERIVED DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - SOURCE
8.1. OVERVIEW
8.2. SOURCE MARKET FORECASTS AND ANALYSIS
8.3. ALGAE
8.3.1. Overview
8.3.2. Algae Market Forecast and Analysis
8.4. INVERTEBRATES
8.4.1. Overview
8.4.2. Invertebrates Market Forecast and Analysis
8.5. MICROORGANISMS
8.5.1. Overview
8.5.2. Microorganisms Market Forecast and Analysis
9. MARINE-DERIVED DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - MODE OF DELIVERY
9.1. OVERVIEW
9.2. MODE OF DELIVERY MARKET FORECASTS AND ANALYSIS
9.3. ANTI-MICROBIAL
9.3.1. Overview
9.3.2. Anti-microbial Market Forecast and Analysis
9.4. ANTI-TUMOR
9.4.1. Overview
9.4.2. Anti-tumor Market Forecast and Analysis
9.5. ANTI-CARDIOVASCULAR
9.5.1. Overview
9.5.2. Anti-cardiovascular Market Forecast and Analysis
9.6. ANTI-VIRAL
9.6.1. Overview
9.6.2. Anti-viral Market Forecast and Analysis
9.7. ANTI-INFLAMMATORY
9.7.1. Overview
9.7.2. Anti-inflammatory Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis
10. MARINE-DERIVED DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - END USERS
10.1. OVERVIEW
10.2. END USERS MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL AND CLINICS
10.3.1. Overview
10.3.2. Hospital and Clinics Market Forecast and Analysis
10.4. PHARMACY
10.4.1. Overview
10.4.2. Pharmacy Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. MARINE-DERIVED DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Marine-derived Drugs Market Overview
11.1.2 North America Marine-derived Drugs Market Forecasts and Analysis
11.1.3 North America Marine-derived Drugs Market Forecasts and Analysis - By Type
11.1.4 North America Marine-derived Drugs Market Forecasts and Analysis - By Source
11.1.5 North America Marine-derived Drugs Market Forecasts and Analysis - By Mode of Delivery
11.1.6 North America Marine-derived Drugs Market Forecasts and Analysis - By End Users
11.1.7 North America Marine-derived Drugs Market Forecasts and Analysis - By Countries
11.1.7.1 United States Marine-derived Drugs Market
11.1.7.1.1 United States Marine-derived Drugs Market by Type
11.1.7.1.2 United States Marine-derived Drugs Market by Source
11.1.7.1.3 United States Marine-derived Drugs Market by Mode of Delivery
11.1.7.1.4 United States Marine-derived Drugs Market by End Users
11.1.7.2 Canada Marine-derived Drugs Market
11.1.7.2.1 Canada Marine-derived Drugs Market by Type
11.1.7.2.2 Canada Marine-derived Drugs Market by Source
11.1.7.2.3 Canada Marine-derived Drugs Market by Mode of Delivery
11.1.7.2.4 Canada Marine-derived Drugs Market by End Users
11.1.7.3 Mexico Marine-derived Drugs Market
11.1.7.3.1 Mexico Marine-derived Drugs Market by Type
11.1.7.3.2 Mexico Marine-derived Drugs Market by Source
11.1.7.3.3 Mexico Marine-derived Drugs Market by Mode of Delivery
11.1.7.3.4 Mexico Marine-derived Drugs Market by End Users
11.2. EUROPE
11.2.1 Europe Marine-derived Drugs Market Overview
11.2.2 Europe Marine-derived Drugs Market Forecasts and Analysis
11.2.3 Europe Marine-derived Drugs Market Forecasts and Analysis - By Type
11.2.4 Europe Marine-derived Drugs Market Forecasts and Analysis - By Source
11.2.5 Europe Marine-derived Drugs Market Forecasts and Analysis - By Mode of Delivery
11.2.6 Europe Marine-derived Drugs Market Forecasts and Analysis - By End Users
11.2.7 Europe Marine-derived Drugs Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Marine-derived Drugs Market
11.2.7.1.1 Germany Marine-derived Drugs Market by Type
11.2.7.1.2 Germany Marine-derived Drugs Market by Source
11.2.7.1.3 Germany Marine-derived Drugs Market by Mode of Delivery
11.2.7.1.4 Germany Marine-derived Drugs Market by End Users
11.2.7.2 France Marine-derived Drugs Market
11.2.7.2.1 France Marine-derived Drugs Market by Type
11.2.7.2.2 France Marine-derived Drugs Market by Source
11.2.7.2.3 France Marine-derived Drugs Market by Mode of Delivery
11.2.7.2.4 France Marine-derived Drugs Market by End Users
11.2.7.3 Italy Marine-derived Drugs Market
11.2.7.3.1 Italy Marine-derived Drugs Market by Type
11.2.7.3.2 Italy Marine-derived Drugs Market by Source
11.2.7.3.3 Italy Marine-derived Drugs Market by Mode of Delivery
11.2.7.3.4 Italy Marine-derived Drugs Market by End Users
11.2.7.4 Spain Marine-derived Drugs Market
11.2.7.4.1 Spain Marine-derived Drugs Market by Type
11.2.7.4.2 Spain Marine-derived Drugs Market by Source
11.2.7.4.3 Spain Marine-derived Drugs Market by Mode of Delivery
11.2.7.4.4 Spain Marine-derived Drugs Market by End Users
11.2.7.5 United Kingdom Marine-derived Drugs Market
11.2.7.5.1 United Kingdom Marine-derived Drugs Market by Type
11.2.7.5.2 United Kingdom Marine-derived Drugs Market by Source
11.2.7.5.3 United Kingdom Marine-derived Drugs Market by Mode of Delivery
11.2.7.5.4 United Kingdom Marine-derived Drugs Market by End Users
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Marine-derived Drugs Market Overview
11.3.2 Asia-Pacific Marine-derived Drugs Market Forecasts and Analysis
11.3.3 Asia-Pacific Marine-derived Drugs Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Marine-derived Drugs Market Forecasts and Analysis - By Source
11.3.5 Asia-Pacific Marine-derived Drugs Market Forecasts and Analysis - By Mode of Delivery
11.3.6 Asia-Pacific Marine-derived Drugs Market Forecasts and Analysis - By End Users
11.3.7 Asia-Pacific Marine-derived Drugs Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Marine-derived Drugs Market
11.3.7.1.1 Australia Marine-derived Drugs Market by Type
11.3.7.1.2 Australia Marine-derived Drugs Market by Source
11.3.7.1.3 Australia Marine-derived Drugs Market by Mode of Delivery
11.3.7.1.4 Australia Marine-derived Drugs Market by End Users
11.3.7.2 China Marine-derived Drugs Market
11.3.7.2.1 China Marine-derived Drugs Market by Type
11.3.7.2.2 China Marine-derived Drugs Market by Source
11.3.7.2.3 China Marine-derived Drugs Market by Mode of Delivery
11.3.7.2.4 China Marine-derived Drugs Market by End Users
11.3.7.3 India Marine-derived Drugs Market
11.3.7.3.1 India Marine-derived Drugs Market by Type
11.3.7.3.2 India Marine-derived Drugs Market by Source
11.3.7.3.3 India Marine-derived Drugs Market by Mode of Delivery
11.3.7.3.4 India Marine-derived Drugs Market by End Users
11.3.7.4 Japan Marine-derived Drugs Market
11.3.7.4.1 Japan Marine-derived Drugs Market by Type
11.3.7.4.2 Japan Marine-derived Drugs Market by Source
11.3.7.4.3 Japan Marine-derived Drugs Market by Mode of Delivery
11.3.7.4.4 Japan Marine-derived Drugs Market by End Users
11.3.7.5 South Korea Marine-derived Drugs Market
11.3.7.5.1 South Korea Marine-derived Drugs Market by Type
11.3.7.5.2 South Korea Marine-derived Drugs Market by Source
11.3.7.5.3 South Korea Marine-derived Drugs Market by Mode of Delivery
11.3.7.5.4 South Korea Marine-derived Drugs Market by End Users
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Marine-derived Drugs Market Overview
11.4.2 Middle East and Africa Marine-derived Drugs Market Forecasts and Analysis
11.4.3 Middle East and Africa Marine-derived Drugs Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Marine-derived Drugs Market Forecasts and Analysis - By Source
11.4.5 Middle East and Africa Marine-derived Drugs Market Forecasts and Analysis - By Mode of Delivery
11.4.6 Middle East and Africa Marine-derived Drugs Market Forecasts and Analysis - By End Users
11.4.7 Middle East and Africa Marine-derived Drugs Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Marine-derived Drugs Market
11.4.7.1.1 South Africa Marine-derived Drugs Market by Type
11.4.7.1.2 South Africa Marine-derived Drugs Market by Source
11.4.7.1.3 South Africa Marine-derived Drugs Market by Mode of Delivery
11.4.7.1.4 South Africa Marine-derived Drugs Market by End Users
11.4.7.2 Saudi Arabia Marine-derived Drugs Market
11.4.7.2.1 Saudi Arabia Marine-derived Drugs Market by Type
11.4.7.2.2 Saudi Arabia Marine-derived Drugs Market by Source
11.4.7.2.3 Saudi Arabia Marine-derived Drugs Market by Mode of Delivery
11.4.7.2.4 Saudi Arabia Marine-derived Drugs Market by End Users
11.4.7.3 U.A.E Marine-derived Drugs Market
11.4.7.3.1 U.A.E Marine-derived Drugs Market by Type
11.4.7.3.2 U.A.E Marine-derived Drugs Market by Source
11.4.7.3.3 U.A.E Marine-derived Drugs Market by Mode of Delivery
11.4.7.3.4 U.A.E Marine-derived Drugs Market by End Users
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Marine-derived Drugs Market Overview
11.5.2 South and Central America Marine-derived Drugs Market Forecasts and Analysis
11.5.3 South and Central America Marine-derived Drugs Market Forecasts and Analysis - By Type
11.5.4 South and Central America Marine-derived Drugs Market Forecasts and Analysis - By Source
11.5.5 South and Central America Marine-derived Drugs Market Forecasts and Analysis - By Mode of Delivery
11.5.6 South and Central America Marine-derived Drugs Market Forecasts and Analysis - By End Users
11.5.7 South and Central America Marine-derived Drugs Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Marine-derived Drugs Market
11.5.7.1.1 Brazil Marine-derived Drugs Market by Type
11.5.7.1.2 Brazil Marine-derived Drugs Market by Source
11.5.7.1.3 Brazil Marine-derived Drugs Market by Mode of Delivery
11.5.7.1.4 Brazil Marine-derived Drugs Market by End Users
11.5.7.2 Argentina Marine-derived Drugs Market
11.5.7.2.1 Argentina Marine-derived Drugs Market by Type
11.5.7.2.2 Argentina Marine-derived Drugs Market by Source
11.5.7.2.3 Argentina Marine-derived Drugs Market by Mode of Delivery
11.5.7.2.4 Argentina Marine-derived Drugs Market by End Users
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MARINE-DERIVED DRUGS MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. MARINE-DERIVED DRUGS MARKET, KEY COMPANY PROFILES
14.1. PFIZER, INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ABBOTT
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. GLAXOSMITHKLINE PLC
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. AKER BIOMARINE AS
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. PHARMA MAR S.A
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. EISAI CO., LTD.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. AKER BIOMARINE AS
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. SEA RUN HOLDINGS, INC.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. APHIOS CORPORATION
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. PHARMA MARINE USA, LLC
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer, Inc.
2. Abbott
3. GlaxoSmithKline PLC
4. Aker BioMarine AS
5. Pharma Mar S.A
6. Eisai Co., Ltd.
7. Aker BioMarine AS
8. Sea Run Holdings, Inc.
9. Aphios Corporation
10. Pharma Marine USA, LLC
11. Perrigo
12. Bayer AG
13. Takeda Pharmaceuticals
14. Sanofi S.A.
15. Seattle Genetics
16. DSM
17. BASF SE
18. Amway
19. Pelagia (EPAX)
20. Croda
21. GNC
22. TerSera Therapeutics
23. Nordic Naturals
24. Carlson Labs
TIPRE00023145
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking